Purple Biotech Ltd. SEC filings PPBT
Purple Biotech Ltd. has 576 filings in SEC EDGAR's recent list, going back to Aug 18, 2014. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 4, 2025 | — |
| CORRESP | Letter to the SEC | Aug 29, 2025 | — |
| CORRESP | Letter to the SEC | Aug 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| DRS | Filing | Jul 10, 2025 | — |
| EFFECT | Filing | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2024 | — |
| D | Filing | Jul 15, 2024 | — |
| EFFECT | Filing | Apr 2, 2024 | — |
| EFFECT | Filing | Nov 14, 2023 | — |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| D | Filing | Oct 31, 2023 | — |
| EFFECT | Filing | May 22, 2023 | — |
| CORRESP | Letter to the SEC | May 18, 2023 | — |
| EFFECT | Filing | Apr 5, 2023 | — |
| CORRESP | Letter to the SEC | Apr 3, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2022 | — |
| 25-NSE | Delisting notice | Nov 23, 2020 | — |
| EFFECT | Filing | Jul 17, 2020 | — |
| EFFECT | Filing | Jul 17, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2020 | — |
| CORRESP | Letter to the SEC | Jul 17, 2020 | — |
| D | Filing | Jul 14, 2020 | — |
| EFFECT | Filing | May 20, 2020 | — |
| UPLOAD | Letter from the SEC | May 20, 2020 | — |
| CORRESP | Letter to the SEC | May 20, 2020 | — |
| D | Filing | May 15, 2020 | — |
| D | Filing | May 4, 2020 | — |
| EFFECT | Filing | Mar 11, 2020 | — |
| CORRESP | Letter to the SEC | Mar 10, 2020 | — |
| CORRESP | Letter to the SEC | Mar 10, 2020 | — |
| D | Filing | Jan 21, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2020 | — |
| EFFECT | Filing | Dec 13, 2019 | — |
| CORRESP | Letter to the SEC | Dec 9, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2019 | — |
| EFFECT | Filing | Sep 27, 2019 | — |
| EFFECT | Filing | Sep 27, 2019 | — |
| CORRESP | Letter to the SEC | Sep 26, 2019 | — |
| CORRESP | Letter to the SEC | Sep 26, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2019 | — |
| D | Filing | Jan 24, 2019 | — |
| EFFECT | Filing | Aug 8, 2018 | — |
| CORRESP | Letter to the SEC | Aug 6, 2018 | — |
| CORRESP | Letter to the SEC | Aug 3, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2018 | — |
| D | Filing | Jun 7, 2018 | — |
| D | Filing | Mar 26, 2018 | — |
| D | Filing | Nov 1, 2017 | — |
| D | Filing | Aug 8, 2017 | — |
| CT ORDER | Filing | Jun 7, 2017 | — |
| EFFECT | Filing | Dec 14, 2016 | — |
| EFFECT | Filing | Dec 13, 2016 | — |
| EFFECT | Filing | Dec 13, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2016 | — |
| CORRESP | Letter to the SEC | Dec 12, 2016 | — |
| AW | Amendment withdrawal request | Dec 12, 2016 | — |
| AW | Amendment withdrawal request | Dec 12, 2016 | — |
| RW | Registration withdrawal request | Dec 12, 2016 | — |
| EFFECT | Filing | Jun 28, 2016 | — |
| CORRESP | Letter to the SEC | Jun 28, 2016 | — |
| CORRESP | Letter to the SEC | Jun 27, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2016 | — |
| D | Filing | May 2, 2016 | — |
| EFFECT | Filing | Mar 23, 2016 | — |
| D | Filing | Feb 4, 2016 | — |
| EFFECT | Filing | Nov 23, 2015 | — |
| CT ORDER | Filing | Nov 23, 2015 | — |
| EFFECT | Filing | Nov 20, 2015 | — |
| CERTNAS | Auto-generated paper document | Nov 19, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2015 | — |
| 8-A12B | Form 8-a12b | Nov 18, 2015 | — |
| CORRESP | Letter to the SEC | Nov 17, 2015 | — |
| CORRESP | Letter to the SEC | Nov 17, 2015 | — |
| DRS/A | Filing | Aug 21, 2015 | — |
| DRSLTR | Filing | Aug 21, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2015 | — |
| DRS | Filing | Jul 20, 2015 | — |
| DRS | Filing | Aug 18, 2014 | — |
Showing 82 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PPBT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Rehovot, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1614744
- Former names
- Kitov Pharma Ltd. (until Dec 10, 2020); Kitov Pharmaceuticals Holdings Ltd. (until Dec 21, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.